Research Webinars, • 8/7/24 Mutation-Specific Epigenetic Reprogramming of Hematopoietic Stem Cells in AML Previous Latest Research Findings From the Ongoing NIH RUNX1 Natural History Study Next An Approach to Screening Drugs for Preventing Disease Progression in Patients with RUNX1-FPD You Might Also Like Crosstalk Between Transcription Factors, Methyltransferases and Tyrosine Kinases RRP Patient Meeting 2023: Upcoming Clinical Studies - Dr. Alan Cantor and Dr. Lea Cunningham Stem Cell Harvesting and Banking Clinical Trial at CHOP RRP Patient Meeting 2023: Upcoming Clinical Studies - Dr. Tim Olson RUNX1 Cancer Disease Biology
Research Webinars, • 8/7/24 Mutation-Specific Epigenetic Reprogramming of Hematopoietic Stem Cells in AML Previous Latest Research Findings From the Ongoing NIH RUNX1 Natural History Study Next An Approach to Screening Drugs for Preventing Disease Progression in Patients with RUNX1-FPD You Might Also Like Crosstalk Between Transcription Factors, Methyltransferases and Tyrosine Kinases RRP Patient Meeting 2023: Upcoming Clinical Studies - Dr. Alan Cantor and Dr. Lea Cunningham Stem Cell Harvesting and Banking Clinical Trial at CHOP RRP Patient Meeting 2023: Upcoming Clinical Studies - Dr. Tim Olson RUNX1 Cancer Disease Biology
